<DOC>
	<DOCNO>NCT01735188</DOCNO>
	<brief_summary>Primary objective : Characterize natural history MoCD type A term survival Secondary objective : 1 . Evaluate blood urine biochemical marker 2 . Evaluate head circumference , seizure activity neurologic outcomes 3 . To evaluate brain MRI 4 . Compare blood urine analysis , head circumference , seizure activity neurologic outcome MRI finding</brief_summary>
	<brief_title>A Natural History Study Molybdenum Cofactor Isolated Sulfite Oxidase Deficiencies</brief_title>
	<detailed_description />
	<mesh_term>Metal Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Amino Acid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Molybdenum</mesh_term>
	<criteria>1 . Both live decease patient age consider study inclusion . 2 . Diagnosis MoCD isolate SOX deficiency 3 . Documented informed consent 1 . MoCD Type A patient Study ALXMCD501 2 . Deceased patient unknown genotype ( Amendment 4 )</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Natural history study</keyword>
</DOC>